Tag: AHA 2019

Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results

George Dangas (Mount Sinai Hospital, New York, USA) told delegates in a late-breaking trial sess...

AHA 2019: ISCHEMIA shows no benefit for revascularisation in patients with stable ischaemic heart disease

The largest trial to date to compare revascularisation with a conservative strategy in patients ...

AHA 2019: Preprocedural COLCHICINE-PCI finds a lowering of inflammation, but no reduction in myocardial injury

Preprocedural administration of an oral colchicine load does not reduce the risk of myocardial i...

AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor

Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor Sy...